Company Overview and News

0
California Resources' Q2 Review: Shifting Momentum

2018-08-14 seekingalpha
There’s a quote that we’ve used before. It’s from hockey legend Wayne Gretzky who said, “I skate to where the puck is going to be, not where it has been.” The quote is fairly self-explanatory and we’ve used it to describe E&P companies that have increased capital expenditures/production in anticipation of higher oil prices. In general, E&P management teams tout the notion that they manage for profitability, regardless of the overall macro environment.
CRC MS

0
Investors Remain Skeptical Of Energy Stocks

2018-08-08 seekingalpha
The concerns started when OPEC+ announced that it would start increasing oil production scaring off the newcomers .
CRC MEG MEGEF GENGF GXE

0
CRC / California Resources Corp. S-8

2018-08-06 sec.gov
Document As filed with the Securities and Exchange Commission on August 6, 2018
CRC

0
California Resources: Another Cash Flow Crash

2018-08-03 seekingalpha
Roughly one-third of consolidated cash flow is in joint ventures where the parent company might not have access to the cash flow.
CRC

0
California Resources (CRC) Reports Q2 Loss, Misses Revenue Estimates

2018-08-03 zacks
California Resources (CRC - Free Report) just came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of $0.05. This compares to loss of $1.83 per share a year ago. These figures are adjusted for non-recurring items.
CRC CY

0
California Resources Corporation (CRC) CEO Todd Stevens on Q2 2018 Results - Earnings Call Transcript

2018-08-03 seekingalpha
Good day and welcome to the California Resources Corporation Second Quarter 2018 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded.
CRC MS

0
California Resources Corporation 2018 Q2 - Results - Earnings Call Slides

2018-08-02 seekingalpha
The following slide deck was published by California Resources Corporation in conjunction with their 2018 Q2 earnings call.
CRC

0
CRC / California Resources Corp. 10-Q (Quarterly Report)

2018-08-02 sec.gov
Document SECURITIES AND EXCHANGE COMMISSION
CRC

0
CRC / California Resources Corp. 8-K (Current Report)

2018-08-02 sec.gov
Document UNITED STATES <
CRC

9
Looming US Sanctions on Iran Could Boost Oil Stocks: 5 Picks

2018-08-01 zacks
The United States is gearing up for military action against Iran so that the key trade waterways in the Middle East remain open. There was much tension between the two countries since President Donald Trump backed out of the 2015 Iran nuclear deal in May, but the scenario worsened after Jul 25, when Iran-backed Houthi rebels attacked two Saudi oil tankers that were passing the Bab al-Mandab Strait.
CRC EPM NOG BCEI EPM-A

14
Oil and Gas - U.S. E&P Stock Outlook: Future Still Promising

2018-07-31 zacks
West Texas Intermediate (or WTI) — a benchmark for oil prices in the United States — recently hit a three-and-a-half year high. The commodity popped above $75 a barrel, meaning that WTI oil surged almost 200% from the dark days of February 2016, when it fell to a 13-year low of around $26 per barrel.
CRC ALGN NOG PVAC PVAYQ PVA BCEI

10
The Zacks Analyst Blog Highlights: JinkoSolar, Hollysys, Woori and China Petroleum

2018-07-30 zacks
Chicago, IL –July 30, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include JinkoSolar (JKS - Free Report) , Hollysys Automation (HOLI - Free Report) , Woori Bank (WF - Free Report) and China Petroleum and Chemical (SNP - Free Report) .
CRC LMT ALGN ATB BCEI WF AJRD SIRI AMP NOC LULU PAA AMWD TSC

12
The Zacks Analyst Blog Highlights: Amazon, Facebook, Thermo Fisher, Home Depot and Progressive

2018-07-30 zacks
Chicago, IL –July 30, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Amazon (AMZN - Free Report) , Facebook (FB - Free Report) , Thermo Fisher (TMO - Free Report) , Home Depot (HD) and Progressive Corp (PGR - Free Report) .
CRC HD LMT FB ALGN PGR BCEI AJRD SIRI AMP NOC LULU PAA AMWD TSC

11
The Zacks Analyst Blog Highlights: Daimler, Ford, Volkswagen, Fiat and Ferrari

2018-07-30 zacks
Chicago, IL –July 30, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Daimler (DDAIF - Free Report) , Ford Motor (F), Volkswagen Aktiengesellschaft (VLKAY - Free Report) , Fiat Chrysler (FCAU - Free Report) and Ferrari (RACE - Free Report)
CRC LMT ALGN BCEI DDAIF AJRD SIRI AMP NOC LULU FCAU PAA AMWD VLKAY TSC

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 13057Q107